In order to confirm our conjecture, we monitored disease process of MDS and found that, not only the expression of FOXO1 gene decreased, but also the expression of functional FOXO1 protein decreased significantly by immunohistochemistry in the progress of the disease. This evidence concerns the gene FOXO1 and myelodysplastic syndrome.